SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,348.93. The last known price of BNB is 702.2705794 USD and is down -0.19 over the last 24 hours. It is currently trading on 3523 active market(s) with $1,103,086,320.06 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

Binances reported major security breach and temporary withdrawal suspension dominate discussion, with traders worried about customer-fund safety, possible outflows, and the exchanges ability to cover losses. Some question the reported account of the incident and see the market reaction as limited, while others warn of deeper downside or an exchange run.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is drawing attention after raising its full-year outlook amid strong shipping demand and freight-rate momentum, bolstering expectations for stronger results and possible dividends. Traders are also debating the uncertain Hapag-Lloyd acquisition: some favor the buyout, while others prefer ZIM to remain independent and return more cash to shareholders.

Compound (COMP) is a cryptocurrency and operates on the Ethereum platform. Compound has a current supply of 10,000,000 with 9,999,999.99995246 in circulation. The last known price of Compound is 20.30398255 USD and is down -0.93 over the last 24 hours. It is currently trading on 652 active market(s) with $11,814,750.57 traded over the last 24 hours. More information can be found at https://www.compound.xyz/.

Compound

Traders are focused on Compounds institutional expansion, including the Institutional Market launch, a treasury-backed finance program, and the V4 roadmap, alongside the tokens limited supply. Bulls see these developments as potential catalysts, while others remain frustrated by COMPs lagging price action and resistance levels.

Uniswap (UNI) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Uniswap has a current supply of 886,374,418.78619706 with 624,126,422.48036204 in circulation. The last known price of Uniswap is 7.08238827 USD and is down -0.58 over the last 24 hours. It is currently trading on 1522 active market(s) with $412,289,518.47 traded over the last 24 hours. More information can be found at https://uniswap.org/blog/uni/.

UniSwap

Traders are focusing on Uniswaps Robinhood integration and its potential to bring more tokenized-asset trading, fees, and UNI buybacks and burns to the protocol. The discussion is largely bullish on the added utility and supply reduction, though some traders question whether the partnerships impact is already reflected in the price and point to continued volatility.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,154,878.82761615 in circulation. The last known price of Hedera is 0.07180731 USD and is down -0.57 over the last 24 hours. It is currently trading on 465 active market(s) with $36,939,739.82 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

A sharp pullback after a rally that traders linked to IBM/Hedera and Nvidia-related enterprise-AI news is driving discussion. Many see the decline as a pump-and-dump or worry about persistent selling, while others are buying the dip and remain optimistic about Hederas enterprise use cases.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

OXY is drawing attention alongside firmer oil prices and supply concerns, with traders also noting OPEC+s decision to keep December production targets steady. Bullish discussion centers on call activity and a possible technical breakout, while some traders question why the shares have not kept pace with crude.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing attention for its steep price decline and concerns about shrinking weekly distributions and NAV erosion as a covered-call fund tied to MSTR and Bitcoin. Bearish traders warn of further losses or another reverse split, while income-focused holders are buying or holding for the payouts and a possible recovery in the underlying.

Amp (AMP) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Amp has a current supply of 99,720,267,351.28921674 with 89,781,193,103.18022 in circulation. The last known price of Amp is 0.00072207 USD and is up 10.61 over the last 24 hours. It is currently trading on 193 active market(s) with $28,619,626.10 traded over the last 24 hours. More information can be found at https://amp.xyz.

AMP Token

AMP has drawn attention after a sharp rally and volume spike, with traders speculating that interest in the connected Anvil/Flexa ecosystem and broader stablecoin-payment developments could benefit the token. Bullish holders see renewed momentum, while skeptics call it a recurring pump and say sustained gains depend on real payment adoption and merchant integrations.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios earnings beat and raised full-year outlook were overshadowed by softer Q4 growth guidance, signaling a slowdown in organic growth and prompting a sharp selloff. Traders are debating whether the decline is a justified earnings reset or an overreaction to otherwise strong results, with some waiting for support to hold before buying.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons Q3 results beat expectations, with strong refining margins and record U.S. refinery throughput driving much of the discussion despite weaker upstream performance. Traders point to bullish call-heavy options activity and new highs, while debating whether refining gains and energy-price tailwinds will last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is expanding its use of human-relevant testing methods across its oncology research programs, seeking to generate more clinically informative preclinical data while reducing the number of animals required for drug development. In an October 7, 2026, company announcement, the Switzerland-based biotechnology company, with [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and additional in vitro findings validating its BiTAC-ADC technology platform at the 17th World ADC Congress in San Diego. The in vivo study demonstrated significant tumor regression in a breast cancer model following a single 3 [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.S. Food and Drug Administration “FDA”-aligned New Approach Methodologies “NAMs” across its preclinical research and development programs. The company said the approach could accelerate clinical advancement, reduce development costs and timelines and significantly reduce animal testing. [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress

VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial partnerships for its technology platforms and products following the completion of its business combination and commencement of Nasdaq trading in June 2026. Xlife Sciences AG (SIX: XLS) said VERAXA secured a financing base to support its next development steps [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is entering a new phase of development following its transition to the NASDAQ market and a series of scientific and corporate milestones that have expanded the company’s focus around its proprietary BiTAC(R) platform. The Swiss biotechnology company began trading on the NASDAQ Capital [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has appointed Raju Willener as chief financial officer, adding a finance executive with more than three decades of international capital-markets experience as the biotechnology company works to advance its oncology pipeline. The appointment is effective immediately. Willener will report to Chief Executive Officer [&#8230;]

VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a time when oncology research is increasingly focused on a difficult question: how can powerful treatments be made more selective without sacrificing their ability to kill cancer cells? The wiss biotechnology company is approaching that problem through a portfolio of antibody-drug [&#8230;]

VERAXA Biotech Designates Raju Willener as CFO

VERAXA Biotech Designates Raju Willener as CFO...

VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer

VERAXA Biotech (NASDAQ: VRXA)&#160;a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, [&#8230;]

VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, and Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, have reached an early research milestone in their collaboration to develop antibody oligonucleotide conjugates (“AOCs”), providing VERAXA with an initial proof point for applying its […]

Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.

Veraxa Biotech AG

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$VRXA It should be an interesting next week during the 17th World ADC Congress/Summit Oct. 12th-Oct. 15th in San Diego USA.

Peter

$VRXA: Veraxa Biotech (+8.3%) reported potent cancer-cell killing by its lead BiTAC candidate across 10 patient-derived non-small cell lung cancer models.

Briefing.com

$VRXA , what is preclinical? "Veraxa Biotech reports new preclinical data supporting BiTAC oncology pipeline, adopts FDA-aligned New Approach Methodologies in preclinical programs"

Mario

$VRXA consistent volume again, but after hours....1,510 last at $$ who cares. Not what I was looking for. 
What I can see here is that the last 3 news releases ALL are pretty much the same, but 3 different  promotional groups. I'm now going to directly try and get a hold of some of the bigger Principles.

$VRXA i think we are going down to 0.20-0.25 before doing a RS then go back to sub 1 again. Foooken hell. I dont think I'll see my 2.74 average ever again.

Aljon Terra

$VRXA That last write-up re: FDA guidelines I thought was extremely positive, yet they didn't say anything about the insider's buying.

Feed

News

Sentiment

Fundamentals

Info

VRXA Veraxa Biotech AG

Fundamentals

Latest VRXA News